Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where S. Kobayashi is active.

Publication


Featured researches published by S. Kobayashi.


Biochemical and Biophysical Research Communications | 1986

An evidence of the peroxidase-dependent oxygen transfer from hydrogen peroxide to sulfides

S. Kobayashi; Minoru Nakano; Toshio Goto; Tokuji Kimura; A. Paul Schaap

Horseradish- and chloro-peroxidase catalyzed oxidation of sulfides have been investigated. Thioanisoles were oxygenated to the corresponding sulfoxides by such peroxidases at the expense of H2O2. Dealkylation was observed only in the chloroperoxidase-dependent oxidations of p-methoxy- and p-iso-propoxy-thioanisoles. The experiments with 18O-labeled H2O2 indicated that an oxygen atom of H2O2 is incorporated into the sulfoxides. These research lead to the conclusion that compound I or II is capable of acting as an oxygen donor as well as an electron acceptor.


Experimental Biology and Medicine | 1981

Contraction of the Canine Basilar Artery following Linoleic, Arachidonic, 13-Hydroperoxylinoleic, or 15-Hydroperoxyarachidonic Acid

Tohru Koide; Yukifumi Noda; Shun'ichi Hata; Katsuaki Sugioka; S. Kobayashi; Minoru Nakano

Abstract The contractile activity of linoleic acid (LA), arachidonic acid (AA), 13l-hydroperoxy-cis-9-trans-11-octadecadienoic acid (13HPLA), or 15l-hydroperoxy-cis-5-cis-8-cis-11-trans-13-eicosatetraenoic acid (15HPAA) was tested on canine basilar artery segments in a small chamber, using serotonin as the reference vasoconstrictor. The cumulative dose–response contraction was approximately 400 times that of serotonin. On the other hand, either 15HPAA or 13HPLA at 10-6 M induced a contraction almost equal to the maximum attained with serotonin (1 × 10-6 M) contraction. The maximal artery response to each of the hydroperoxy fatty acids was almost 1.4 times stronger than that obtained with serotonin, LA, or AA.


Biochemical and Biophysical Research Communications | 1980

Excitation of indole acetate in myeloperoxidase-H2O2 system: Possible formation of indole acetate cation radical

S. Kobayashi; Katsuaki Sugioka; Minoru Nakano; Choichi Takyu; Akio Yamagishi; Humio Inaba

Abstract Myeloperoxidase-H 2 O 2 -indole acetate system at pH 7.4 emitted light in visible region. Luminescent spectrum showed a weak peak at or near 480 nm and prominent peaks at or near 550, 580, and 620 nm with deep troughs near 500 and 600 nm. In some cases, no definite peak emissions near 550 and 580 nm, but a prominent broad emission between 550 and 580 nm, is observed. Such spectral patterns in the region of 510 to 620 nm were quite similar to those report for the luminescence of photo-products formed from the indole analogs (tryptophan and indole) in 50% alcohol irradiated by U.V. (365 nm) at 77°K, assuming red shift (20–25 nm) by solvent effect. Possible formation of indole acetate cation radical (a precursor of excited indole acetate) was discussed.


Biochemical and Biophysical Research Communications | 1986

Cyclo (His-Pro), a metabolite of thyrotropin-releasing hormone: specific binding to rat liver membranes.

Masatomo Mori; Masanobu Yamada; Masafumi Yamaguchi; Mitsuo Suzuki; Kihachi Ohshima; Isao Kobayashi; S. Kobayashi

[3H]cyclo(His-Pro) bound with high affinity (59 nM) to a single class of sites in rat liver plasma membranes, without significant tracer degradation during equilibration for 60 min at 0 degrees C. Binding was specific and saturable (3.9 pmol/mg protein), and were increased by the addition of K+, Mg++ and Na+ at optimal concentrations, but not of Ca++ at all concentrations tested. In vivo administration of cyclo(His-Pro), but not thyrotropin-releasing hormone, to rats caused the downregulation of cyclo(His-Pro)-binding sites with decreases in specific binding numbers but did not change binding affinity.


Neuropeptides | 1990

Stimulation by a TRH precursor, TRH-Gly, of TSH and PRL secretion in rats: Effect of starvation

M. Mori; Masami Murakami; Tokuji Iriuchijima; Kazuya Miyashita; Teturou Satoh; T. Monden; Toshio Michimata; Isao Kobayashi; S. Kobayashi

The hypophysial activities of a possible direct precursor of thyrotropin (TSH)-releasing hormone (TRH), TRH-Gly, were evaluated in estrogen, progesterone-primed rats under urethane anesthesia. Intravenous administration of TRH-Gly in doses of 2-200 micrograms caused a significant and dose-dependent increase in blood TSH and prolactin (PRL). The stimulatory activity of TRH-Gly was 170 to 400-times less potent than that of TRH. The lower potency was confirmed by the action of TRH-Gly on the anterior pituitary cells in vitro. In starved rats, TRH-Gly apparently stimulated TSH and PRL secretion in a dose-dependent manner, and the stimulatory activity increased in starved rats as compared to normal controls. TRH-Gly did not affect [3H-MeHis]TRH binding in pituitary plasma membranes. These data imply that large amounts of TRH-Gly may have significant biological activities and these are potentiated in the starved condition.


Journal of Endocrinological Investigation | 1986

Thyrotropin-releasing hormone stimulation of thyrotropin secretion is suppressed by calcium ion antagonists that block transmembrane influx and intracellular mobilization of calcium ion in human subjects

Masanobu Yamada; Masatomo Mori; Masafumi Yamaguchi; H. Akiyama; S. Shiono; Isao Kobayashi; S. Kobayashi

To evaluate whether extracellular and intracellular calcium ion may be involved in the regulation of TSH secretion in response to TRH in human subjects, the TSH blood level was determined in normal man before and after administration of two kinds of calcium ion antagonists, nifedipine that blocks transmembrane influx of calcium ion and nicorandil that inhibits mobilization of intracellular calcium ion. Administration of nifedipine and nicorandil significantly decreased the blood level of TSH stimulated by TRH, although calcium ion antagonistsdid not affect the basal level of TSH. The blood level of neither T4, T3, free T4, free T3, nor reverse T3 was altered by administration of calcium ion antagonists. The present study indicates that cytoplasmic calcium ion derived from the extracellular and intracellular sources plays a pivotal role in the controlling of TRH-stimulated TSH secretion in human subjects.


Journal of Internal Medicine | 1991

Central hypothyroidism due to isolated TRH deficiency in a depressive man

Masatomo Mori; Y. Shoda; Masanobu Yamada; Masami Murakami; Tokuji Iriuchijima; Kihachi Ohshima; Isao Kobayashi; S. Kobayashi

Abstract. A depressive man was evaluated for developing chronic fatigue and cold intolerance, in whom laboratory findings showed decreased thyroid hormone levels (T4, 2.7 μg dl−1; T3, 0.76 ng ml−1) with normal blood levels of TSH. A single bolus injection of TRH (500 μg) significantly stimulated prolactin secretion, but did not cause an increase in blood TSH levels (basal level, 1.2 μU ml−1 vs. 1.3 μU ml−1 30 min after injection). By contrast, TRH‐induced TSH stimulation occurred after repeated injection of TRH for 4 consecutive days (basal level, 1.5 μU ml−1 vs. 5.6 μU ml−1 30 min after injection). Blood thyroid hormone concentrations were restored to normal levels after long‐term administration of TRH. Other pituitary functions remained unchanged. A diagnosis of central hypothyroidism due to isolated TRH deficiency was made in this case, and the data presented here indicate that partial resistance of pituitary thyrotrophs to TRH may be associated with depression.


Journal of Endocrinological Investigation | 1991

Involvement of interleukin-1 in the inhibition of in vivo insulin release: possible role of adrenal glands

Hiroyuki Shimizu; Yutaka Uehara; Y. Shimomura; Mayumi Negishi; Isao Kobayashi; S. Kobayashi

The effect of recombinant human interleukin-1 beta (rhlL-1b) on in vivo insulin secretion was examined in intact and adrenalectomized (ADX) rats under conscious and pentobarbital anesthetized conditions. In conscious rats, rhlL-1b dosedependently decreased blood glucose levels at 2 h in both groups and significantly inhibited insulin release only at doses of 1 and 10 µg/kg in ADX rats. Under pentobarbital anesthesia, rhlL-1b administration decreased blood glucose levels 2 h later in both intact and ADX rats and resulted in severe hypoglycemia in ADX rats. At 2 h later, rhlL-1b significantly suppressed insulin release by pentobarbital injection in both intact and ADX rats. It is concluded that rhlL-1b suppresses in vivo insulin secretion in conscious ADX and anesthetized rats.


Neuropeptides | 1991

Recognition by anti-idiotypic anti-thyrotropin-releasing hormone (TRH) antibody of rat TRH receptors

Teturou Satoh; M. Mori; Masami Murakami; Tokuji Iriuchijima; Masanobu Yamada; Isao Kobayashi; S. Kobayashi

We asked whether anti-idiotypic antibodies raised against anti-TRH antibody could bind to TRH receptors in the rat anterior pituitary and brain. Six rabbits were immunized with IgG from a rabbit anti-TRH antiserum. One anti-idiotypic antibody caused strong, dose-dependent inhibition in anti-TRH antibody-binding to [125]I-TRH. This inhibition was not observed after treatment with goat anti-rabbit IgG antibody. The anti-idiotypic anti-TRH antibody significantly immunoprecipitated digitonin-solubilized pituitary TRH receptors. When eluates of digitonin-solubilized membranes which were adsorbed by either an anti-idiotypic anti-TRH IgG-, normal rabbit IgG-linked affinity column or control column were analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis and visualized by silver stain, only the former eluate showed two bands under nonreducing conditions; one corresponded to a molecular weight marker of 200K, the other to 100K. Western blotting analysis with an anti-idiotypic anti-TRH antiserum showed a single band of molecular weight 56K under reducing conditions. The present study indicates that one can make anti-idiotypic antibodies that specifically recognize TRH receptors.


Journal of Endocrinological Investigation | 1989

Diabetes insipidus with spontaneous remission

Kihachi Ohshima; Shuichi Okada; T. Onai; Mitsuhiko Umahara; Masatomo Mori; Isao Kobayashi; S. Kobayashi; S. Katakai

Pathogenesis of idiopathic diabetes insipidus is unknown and the clinical course of the disease is permanent. However, we observed one patient who was diagnosed of idiopathic diabetes insipidus spontaneously reverted after approximately 13 months. The cause and pathogenesis of the disease were not evident. However, some reversible abnormalities should have been encountered in the hypothalamic-neurohypophyseal system. It is suggested that some unknown reversible impairments of the supraopticohypophyseal tract can cause diabetes insipidus. This case represents a well-documented description of idiopathic diabetes insipidus with spontaneous remission.

Collaboration


Dive into the S. Kobayashi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge